Ditch Big Tech and Buy These 3 Popular Stocks in 2025 Instead
He dominated the market in the seven, 2023 and 2024. However, this year has not survived these stocks until Hype. For example, Roundhill is essentially of the magnificent seven ETF (MAG). In contrast, the S&P 500 index ($ SPX) increased by about 4%. This is surprising that these stocks have pioneered most of the earnings of stock exchanges in the last three years.
But now a new group of popular stocks are getting. Wall Street is starting to throw seven magnificent seven more and more in favor of future stocks. Let’s see if you have three names to see if you have a good idea to do the same.
Palantir’s (PLTR) last year’s price action should remind NVIDIA’s price action from mid -2022 to mid -2014. PLTR Stock has exceeded expectations and used even the most of the Taurus analysts.
Better performance was so great that the stock is traded on sales of 1,166 times more and more than 115 times. Most investors would tell you that it was inevitable in the long run, and probably right. However, the same investors were wrong about how far this meaning could go.
High efficiency savings offers
The price targets go to $ 155 here and reversal about 9%. I would buy stock if you only get a negative risk of high -digit. Palantir is an extraordinary company, but the pendulum has not yet been seen whether or not to maintain a Dotcom Esque premium after swinging in another way.
Unitedhealth (UNH) is far from the PLTR stock right now. The company missed its 1st quarter earnings, and in 2025, more than one negative catalysts, which caused the stock price to be reduced by almost half.
However, UNH is now sitting at prices too good to ignore. Unitedhealth’s faces no longer have the possibility of lingering for years, so the management may begin to overcome earning forecasts as usual, and if the organizers continue to be soft, a rapid recovery may be a rapid recovery. I think this is a solid purchase. In Life-One Dip, you receive the American largest health insurance company. UNH stock may decrease further, but the risk-ie ratio is distorted in your favor.
